Concepedia

Stephanie E. Barrett

SE

Statistics

Publications

11

Citations

421

H-Index

11

Active since

2014

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Ghent University Hospital

Stephanie E. Barrett is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, drug delivery, and pharmaceutics.

Publications per year

2014–2022

11

Publications

11

Extended-Duration MK-8591-Eluting Implant as a Candidate for HIV Treatment and Prevention

Stephanie E. Barrett, Ryan S. Teller, Seth Forster et al. · Antimicrobial Agents and Chemotherapy · 2018 · 133 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial

Randolph P. Matthews, Munjal Patel, Stephanie E. Barrett et al. · Nature Medicine · 2021 · 69 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +15

In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection

Perry Tsai, Guoxin Wu, Caroline Baker et al. · Retrovirology · 2016 · 67 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Development of a liver-targeted siRNA delivery platform with a broad therapeutic window utilizing biodegradable polypeptide-based polymer conjugates

Stephanie E. Barrett, Rob S. Burke, Marc Abrams et al. · Journal of Controlled Release · 2014 · 31 citations

Pharmacy, Pharmaceutics, Pharmacology +16

A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial of Radiopaque Islatravir-Eluting Subdermal Implants for Pre-exposure Prophylaxis Against HIV-1 Infection

Randolph P. Matthews, Xiaowei Zang, Stephanie E. Barrett et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2022 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

1–5 of 11